You are here


An analysis of two databases found that measuring frailty could help predict mortality and functional status at six months or later after older adults undergo cardiac surgery.

Recent Headlines

Digital aide may improve diabetes, hypertension treatment

A new study shows the potential for digital health offerings to improve care for patients with hypertension and Type 2 diabetes by reducing blood pressure and LDL cholesterol levels while leading to increased control of blood pressure.

Breaking Through IT Barriers

For this issue, Cardiovascular Business invited executives from five cardiovascular IT companies to join us for an hour. They tackled every question we asked and more.

Researchers assess the 515 Program Initiative for high-risk devices

Using the Impella 2.5 percutaneous ventricular assist device (Abiomed) as an example, a group of authors recently outlined the process manufacturers must go through to market a device.

To Scribe or Not to Scribe: Cardiologists Seek Solutions for Electronic Health Record Woes

Physicians and patients are seeing less of each other over the barrier of computer screens. Is hiring scribes the answer?

Popular blood pressure app has inaccurate readings

Measuring blood pressure? There’s an app for that. Unfortunately, it may not be accurate. A recent analysis of adults in Baltimore found a popular smartphone-based blood pressure app generated a high percentage of inaccurate readings.

Industry Talks IT: Innovation, What Cardiologists Want & What’s Next

Executives from GE Healthcare, McKesson, Merge Healthcare, Philips and Siemens Healthcare joined Cardiovascular Business for a candid discussion about cardiologists’ information technology concerns and questions.

St. Jude Medical launches new OPTIS Mobile System in Europe and Japan

St. Jude Medical, Inc., has launched its OPTIS Mobile System in Europe and Japan, the company announced today in a press release.

FDA approves Medtronic's MRI conditional CRT defibrillators for heart failure patients

The FDA has approved the first MRI conditional cardiac resynchronization therapy defibrillators (CRT-Ds) to treat patients with heart failure and reduce the risk of sudden cardiac arrest.

Siemens' PET/CT system receives FDA clearance

Siemens Healthcare has received 510(k) clearance from the FDA for the Biograph Horizon PET/CT system, which enables physicians to visualize small lesions early.

Health Diagnostics Laboratory files Chapter 11 liquidation plan

Health Diagnostics Laboratory, a bankrupt cardiac biomarker laboratory, filed a Chapter 11 liquidation plan, Richmond BizSense reports. In April, Health Diagnostics Laboratory agreed to pay $47 million to settle allegations from the Department of Justice that it paid doctors in exchange for patient referrals and billed Medicare for unnecessary testing.